D82.1

Clinical Causes: Genetic mutation affecting chromosome 22q11.2 region De novo mutations (new mutations not inherited from parents) Inheritance pattern typically autosomal dominant but often sporadic

Key Symptoms: Impaired immune system leading to increased susceptibility to infections Congenital heart defects such as tetralogy of Fallot and interrupted aortic arch Distinctive facial features including a long face, prominent chin, and low-set ears Cleft palate or other craniofacial anomalies Hypocalcemia causing symptoms like muscle cramps and seizures Developmental delays and learning difficulties Hearing loss Speech and feeding difficulties in infants

Diagnosis Path: Diagnosis of DiGeorge's syndrome involves a combination of clinical evaluation and laboratory tests. Key diagnostic procedures include: - **Genetic testing:** Fluorescence in situ hybridization (FISH) or microarray analysis to detect deletions in chromosome 22q11.2. - **Immunological assessment:** Blood tests to evaluate T-cell counts and immune function. - **Echocardiogram:** To identify any congenital heart defects. - **Calcium level tests:** To detect hypocalcemia. Early diagnosis is crucial for managing health complications and implementing appropriate interventions.

Treatment Protocols: Management of DiGeorge's syndrome is tailored to the individual's specific symptoms and may involve various healthcare specialties. Common approaches include: - **Immunological support:** Including antibiotics for infections, and in some cases, thymus transplantation or thymic tissue implantation. - **Cardiac surgery:** To correct congenital heart defects. - **Calcium and vitamin D supplementation:** To address hypocalcemia. - **Speech and developmental therapy:** To assist with speech delays and learning difficulties. - **Regular monitoring:** Ongoing assessment of immune function, heart health, and developmental progress. Supportive care and early interventions play a vital role in improving outcomes for those affected by DiGeorge's syndrome.